Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc. (FHTX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · FHTX · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Foghorn Therapeutics Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
FHTX insider buying and selling by quarter
FHTX insider selling · FHTX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · FHTX ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
FHTX executive sell shares · FHTX board member insider trading · FHTX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 10, 2026 | GOTTSCHALK ADRIAN CEO · Director | Gift | 59,208 | — | Form 4 |
| Apr 10, 2026 | GOTTSCHALK ADRIAN CEO · Director | Gift | 59,208 | — | Form 4 |
| Apr 9, 2026 | GOTTSCHALK ADRIAN CEO · Director | Gift | 47,497 | — | Form 4 |
| Apr 9, 2026 | GOTTSCHALK ADRIAN CEO · Director | Gift | 47,497 | — | Form 4 |
| Apr 25, 2025 | GOTTSCHALK ADRIAN CEO · Director | Gift | 300,000 | — | Form 4 |
| Apr 25, 2025 | GOTTSCHALK ADRIAN CEO · Director | Gift | 300,000 | — | Form 4 |
| Apr 9, 2025 | GOTTSCHALK ADRIAN CEO · Director | Gift | 197,906 | — | Form 4 |
| Apr 9, 2025 | GOTTSCHALK ADRIAN CEO · Director | Gift | 197,906 | — | Form 4 |
| Sep 20, 2024 | Costa Carlos CPO | Option | 35,756 | $133K | Form 4 |
| Sep 23, 2024 | Costa Carlos CPO | Option | 857 | $3K | Form 4 |
| Sep 23, 2024 | Costa Carlos CPO | Sale | 857 | $9K | Form 4 |
| Sep 20, 2024 | Costa Carlos CPO | Sale | 35,756 | $359K | Form 4 |
| Sep 18, 2024 | Costa Carlos CPO | Option | 11,574 | $43K | Form 4 |
| Sep 18, 2024 | Costa Carlos CPO | Sale | 11,574 | $116K | Form 4 |
| Sep 17, 2024 | Costa Carlos CPO | Option | 10,272 | $38K | Form 4 |
| Sep 16, 2024 | Costa Carlos CPO | Option | 400 | $1K | Form 4 |
| Sep 17, 2024 | Costa Carlos CPO | Sale | 10,272 | $103K | Form 4 |
| Sep 16, 2024 | Costa Carlos CPO | Sale | 400 | $4K | Form 4 |
| Sep 9, 2024 | Bellon Steven F. Chief Scientific Officer | Sale | 20,000 | $190K | Form 4 |
| Mar 11, 2024 | Cavalie Fanny Chief Strategy/Bus Ops Officer | Sale | 11,000 | $72K | Form 4 |
| Aug 16, 2023 | Agresta Samuel Chief Medical Officer | Option | 311,297 | $1.16M⚡ | Form 4 |
| Aug 16, 2023 | Agresta Samuel Chief Medical Officer | Sale | 311,297 | $2.57M⚡ | Form 4 |
| Aug 17, 2023 | GOTTSCHALK ADRIAN CEO · Director | Gift | 63,000 | — | Form 4 |
| Aug 17, 2023 | GOTTSCHALK ADRIAN CEO · Director | Gift | 63,000 | — | Form 4 |
| May 26, 2023 | GOTTSCHALK ADRIAN CEO · Director | Gift | 300,000 | — | Form 4 |
Bellon Steven F.
Chief Scientific Officer
Date
Sep 9
Shares
20,000
Price
$9.50
Value
$190K
Cavalie Fanny
Chief Strategy/Bus Ops Officer
Date
Mar 11
Shares
11,000
Price
$6.56
Value
$72K
Agresta Samuel
Chief Medical Officer
Date
Aug 16
Shares
311,297
Price
$3.72
Value
$1.16M ⚡
Agresta Samuel
Chief Medical Officer
Date
Aug 16
Shares
311,297
Price
$8.25
Value
$2.57M ⚡
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About FHTX insider trading
FHTX insider trades
Foghorn Therapeutics Inc. (FHTX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including GOTTSCHALK ADRIAN (CEO · Director). Over the past 12 months, 1 insiders have filed transactions with the SEC. FHTX insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Foghorn Therapeutics Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
FHTX insider trading · 5 questionsThe insiders of Foghorn Therapeutics Inc. (FHTX) include executives and directors such as GOTTSCHALK ADRIAN (CEO · Director), among others. Over the past 12 months, 1 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026